Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT04690426 | PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers | PHASE1 | COMPLETED | 32 | — | — | Dec 1, 2020 | Dec 1, 2021 | Jul 24, 2022 | - | — |
| Name | Type | Description |
|---|---|---|
| PRV-101 | BIOLOGICAL | Coxsackie Virus B vaccine |
| Placebo | OTHER | Placebo |